scholarly article | Q13442814 |
P356 | DOI | 10.1373/CLINCHEM.2011.176396 |
P698 | PubMed publication ID | 22427353 |
P50 | author | Miguel A Lasunción | Q40744743 |
Manuel Luque-Ramírez | Q43185417 | ||
Héctor Escobar Morreale | Q43185421 | ||
Maria Vinaixa | Q52278264 | ||
Xavier Correig | Q53340599 | ||
Sara Samino | Q56084646 | ||
María Insenser | Q81499543 | ||
P2093 | author name string | M. A. Lasuncion | |
M. Insenser | |||
M. Luque-Ramirez | |||
P4510 | describes a project that uses | gas chromatography-mass spectrometry | Q873009 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
polycystic ovary syndrome | Q500816 | ||
polycystic ovary | Q5547896 | ||
heterogeneity | Q928498 | ||
P304 | page(s) | 999-1009 | |
P577 | publication date | 2012-03-16 | |
P1433 | published in | Clinical Chemistry | Q849687 |
P1476 | title | Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS | |
P478 | volume | 58 |
Q87398077 | Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients |
Q37640691 | Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population. |
Q38776405 | Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome |
Q26739194 | Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated? |
Q33593356 | Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep |
Q33591287 | Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women |
Q37512804 | Electrospray Quadrupole Travelling Wave Ion Mobility Time-of-Flight Mass Spectrometry for the Detection of Plasma Metabolome Changes Caused by Xanthohumol in Obese Zucker (fa/fa) Rats |
Q47152469 | Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients |
Q53362637 | Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition. |
Q37501409 | Metabolic heterogeneity of follicular amino acids in polycystic ovary syndrome is affected by obesity and related to pregnancy outcome. |
Q34496769 | Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis |
Q64058719 | Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study |
Q64094829 | Metabolomics of Dynamic Changes in Insulin Resistance Before and After Exercise in PCOS |
Q43852376 | Metformin in women with PCOS, pros |
Q26752564 | Poly Cystic Ovarian Syndrome: An Updated Overview |
Q38258968 | Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity |
Q52345007 | Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. |
Q36560506 | Targeted metabolomics finds its mark in diabetes research |
Q36943683 | Targets to treat metabolic syndrome in polycystic ovary syndrome |
Search more.